SENORES PHARMACEUTICALS
Back to Balance Sheet
|
SENORES PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,604 Cr | ₹1,208 Cr | ₹607 Cr | ₹131 Cr | ₹59 Cr |
What is the latest Total Liabilities ratio of SENORES PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹1,604 Cr |
| Mar2025 | ₹1,208 Cr |
| Mar2024 | ₹607 Cr |
| Mar2023 | ₹131 Cr |
| Mar2022 | ₹59 Cr |
How is Total Liabilities of SENORES PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,604 Cr | 32.74 | |
| Mar2025 | ₹1,208 Cr | 99.06 | |
| Mar2024 | ₹607 Cr | 363.13 | |
| Mar2023 | ₹131 Cr | 123.26 | |
| Mar2022 | ₹59 Cr | - | |
Compare Total Liabilities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹5,250.1 Cr | -2.8% | -13.4% | 47.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | -2.8% |
-13.4% |
47.5% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses